Advaxis to Present at the Noble Financial Sixth
Annual Equity Conference – ONTRACK 2010
Chairman/CEO Thomas A. Moore to Discuss Clinical Trial Progress
Place: Hard Rock Hotel, Hollywood, Florida | Date: June 7, 2010 |Time: 9:30 A.M. EDT
Noble Financial ONTRACK 2010 Equity Conference
May 25, 2010 01:53 PM Eastern Daylight Time
NORTH BRUNSWICK, N.J.--(EON: Enhanced Online News)--Chairman/CEO Thomas A. Moore of Advaxis,
Inc., (OTCBB: ADXS), the live, attenuated Listeria monocytogenes (Lm) immunotherapy company, will present
at the Noble Financial Sixth Annual Equity Conference at 9:30a.m. EDT on June 7, 2010 at the Hard Rock Hotel in
The presentation will be webcast – audio, video, PowerPoint - live, and available for viewing at www.advaxis.com
or through the Noble Financial websites www.ontrack10.com or www.nobleresearch.com.
For those interested in participating in the webcast, please register at least 10 minutes prior to the start of the
presentation to ensure timely access. You will need the SilverLight viewer (a free download from presentation link)
to participate. In addition, the webcast and associated collateral material(s) will be archived on the Company’s
website for 90 days following the event.
About Noble Financial
Noble Financial Capital Markets was established in 1984 and is an equity research driven, full-service investment
banking boutique focused on small-cap, emerging growth companies. The company has offices in New York,
Boston, New Jersey, St Louis and Boca Raton.
About Advaxis, Inc.
Advaxis is a biotechnology company developing proprietary, live, attenuated Listeriamonocytogenes (Listeria)
vaccines that deliver engineered tumor antigens, which stimulate multiple, simultaneous immunological mechanisms to
fight cancer. Today, the Company has nine (9) distinct, cancer-fighting constructs in various stages of development,
directly and through strategic collaborations with such recognized sites of excellence as the City of Hope, the